| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for ABBOTINDIA from our risk checks.
Abbott India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹28,589.10 |
| 52 Week High | ₹29,638.95 |
| 52 Week Low | ₹22,000.00 |
| Beta | 0.033 |
| 11 Month Change | 4.09% |
| 3 Month Change | 9.35% |
| 1 Year Change | 22.46% |
| 33 Year Change | 63.65% |
| 5 Year Change | 231.30% |
| Change since IPO | 3,627.39% |
Recent News & Updates
Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13
Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Recent updates
Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year
May 12Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?
Oct 25Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?
Oct 04Why Abbott India Limited (NSE:ABBOTINDIA) Should Be In Your Dividend Portfolio
Sep 13Abbott India Limited (NSE:ABBOTINDIA) Looks Interesting, And It's About To Pay A Dividend
Aug 23Is Abbott India's (NSE:ABBOTINDIA) 295% Share Price Increase Well Justified?
Aug 17Shareholder Returns
| ABBOTINDIA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.9% | 2.1% | 1.1% |
| 1Y | 22.5% | 51.0% | 45.1% |
Return vs Industry: ABBOTINDIA underperformed the Indian Pharmaceuticals industry which returned 51% over the past year.
Return vs Market: ABBOTINDIA underperformed the Indian Market which returned 45.1% over the past year.
Price Volatility
| ABBOTINDIA volatility | |
|---|---|
| ABBOTINDIA Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ABBOTINDIA has not had significant price volatility in the past 3 months.
Volatility Over Time: ABBOTINDIA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1910 | 3,814 | Swati Dalal | www.abbott.co.in |
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products.
Abbott India Limited Fundamentals Summary
| ABBOTINDIA fundamental statistics | |
|---|---|
| Market cap | ₹608.21b |
| Earnings (TTM) | ₹12.01b |
| Revenue (TTM) | ₹58.49b |
50.6x
P/E Ratio10.4x
P/S RatioIs ABBOTINDIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABBOTINDIA income statement (TTM) | |
|---|---|
| Revenue | ₹58.49b |
| Cost of Revenue | ₹32.33b |
| Gross Profit | ₹26.16b |
| Other Expenses | ₹14.15b |
| Earnings | ₹12.01b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 565.30 |
| Gross Margin | 44.73% |
| Net Profit Margin | 20.54% |
| Debt/Equity Ratio | 0% |
How did ABBOTINDIA perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield73%
Payout RatioDoes ABBOTINDIA pay a reliable dividends?
See ABBOTINDIA dividend history and benchmarks| Abbott India dividend dates | |
|---|---|
| Ex Dividend Date | Jul 19 2024 |
| Dividend Pay Date | Sep 07 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 52 days |
Does ABBOTINDIA pay a reliable dividends?
See ABBOTINDIA dividend history and benchmarks